Use the Back button in your browser to see the other results of your search or to select another record.
Lifestyle modification in older versus younger patients with coronary artery disease [with consumer summary] |
Jepma P, Jorstad HT, Snaterse M, ter Riet G, Kragten H, Lachman S, Minneboo M, Boekholdt SM, Peters RJ, Scholte op Reimer W |
Heart 2020 Jul;106(14):1066-1072 |
clinical trial |
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
OBJECTIVE: To compare the treatment effect on lifestyle-related risk factors (LRFs) in older (>= 65 years) versus younger (< 65 years) patients with coronary artery disease (CAD) in the Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists 2 (RESPONSE-2) trial. METHODS: The RESPONSE-2 trial was a community-based lifestyle intervention trial (n = 824) comparing nurse-coordinated referral with a comprehensive set of three lifestyle interventions (physical activity, weight reduction and/or smoking cessation) to usual care. In the current analysis, our primary outcome was the proportion of patients with improvement at 12 months follow-up (n = 711) in >= 1 LRF stratified by age. RESULTS: At baseline, older patients (n = 245, mean age 69.2 +/- 3.9 years) had more adverse cardiovascular risk profiles and comorbidities than younger patients (n = 579, mean age 53.7+/-6.6 years). There was no significant variation on the treatment effect according to age (p value treatment by age 0.45, OR 1.67, 95% CI 1.22 to 2.31). However, older patients were more likely to achieve >= 5% weight loss (OR old 5.58, 95% CI 2.77 to 11.26 versus OR young 1.57, 95% CI 0.98 to 2.49, p = 0.003) and younger patients were more likely to show non-improved LRFs (OR old 0.38, 95% CI 0.22 to 0.67 versus OR young 0.88, 95% CI 0.61 to 1.26, p = 0.01). CONCLUSION: Despite more adverse cardiovascular risk profiles and comorbidities among older patients, nurse-coordinated referral to a community-based lifestyle intervention was at least as successful in improving LRFs in older as in younger patients. Higher age alone should not be a reason to withhold lifestyle interventions in patients with CAD.
|